Information × Registration Number 2116U004029, Article popup.category Thesis Title popup.author popup.publication 01-01-2016 popup.source_user Сумський державний університет popup.source http://essuir.sumdu.edu.ua/handle/123456789/47871 popup.publisher Sumy State University Description Introduction: Anticoagulation with vitamin K antagonist (VKA) has been an enduring gold standard for stroke prevention in atrial fibrillation (AF). But the potential for serious bleeding complications of the drug remains a problem for the safe use of drug. Aim: Examine the prevalence of thromboembolic and bleeding complications in patients with non-valvular atrial fibrillation who receiving warfarin. popup.nrat_date 2025-05-12 Close
Article
Thesis
:
published. 2016-01-01;
Сумський державний університет, 2116U004029